• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
855.7849313
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
37.82
60513.73
EPS(TTM)
Face Value()
Div & Yield %
56.7
1
0.12
 

Vani Commercials standalone net profit declines 25.00% in the March 2026 quarter
May 22,2026
Net profit of Vani Commercials declined 25.00% to Rs 0.09 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales reported to Rs 1.55 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit declined 25.00% to Rs 0.36 crore in the year ended March 2026 as against Rs 0.48 crore during the previous year ended March 2025. Sales rose 68.44% to Rs 5.71 crore in the year ended March 2026 as against Rs 3.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.550 0 5.713.39 68
OPM %29.030 -36.9536.58 -
PBDT0.140.37 -62 0.810.60 35
PBT0.090.34 -74 0.650.48 35
NP0.090.12 -25 0.360.48 -25